Maropitant Market

Maropitant Market Size, Share & Industry Analysis, By Source (Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers) By End-Use Industries (Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035 

The Maropitant market is projected to grow at a CAGR of 5.3% from 2025 to 2035, driven by increasing demand for effective antiemetic therapies in veterinary medicine, especially for companion animals. Maropitant is a neurokinin-1 (NK1) receptor antagonist that works by blocking substance P, a key neurotransmitter involved in the vomiting reflex in the central nervous system. It is widely used to prevent and treat acute vomiting, motion sickness, and chemotherapy-induced nausea in dogs and cats.

Market growth is supported by the growing pet population, rising veterinary visits, and increasing adoption of advanced therapeutics in animal healthcare. Maropitant is also favored for its safety profile, availability in both injectable and oral formulations, and broad-spectrum efficacy across various causes of vomiting. The drug, marketed under brand names like Cerenia, has become a standard in preoperative protocols and supportive care during surgical or chemotherapy procedures.

Regionally, North America leads the Maropitant market due to high rates of pet ownership, well-established veterinary care systems, and greater awareness of pet well-being. Europe follows closely, supported by strong adoption in veterinary practices across the UK, Germany, and France. The Asia-Pacific region is expected to show robust growth over the forecast period, driven by rising companion animal adoption, growing middle-class income, and expanding access to veterinary pharmaceuticals in countries like China, India, and Japan.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Maropitant
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
    • Pharmaceutical Manufacturers (Branded & Generic)
    • Contract Manufacturing Organizations (CMOs)
    • Research-Grade Suppliers
  • Key End-Use Industries
    • Pharmaceutical Industry.
    • Hospitals & Clinics.
    • Research Institutions.
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Maropitant?
Maropitant is a neurokinin-1 (NK1) receptor antagonist used in veterinary medicine to prevent and treat vomiting and nausea in dogs and cats. It works by blocking the binding of substance P—a key neurotransmitter involved in vomiting—to NK1 receptors in the central nervous system.
What is the market growth of Maropitant?
The global Maropitant market is projected to grow at a CAGR of 5.3% from 2025 to 2035. Growth is supported by the rising number of pet adoptions, increased awareness of animal health, and greater demand for quality-of-life therapies for companion animals.
What are the drivers of the Maropitant market?
Key market drivers include the growing veterinary pharmaceutical sector, increased focus on pet wellness and travel safety, and the rising incidence of chemotherapy and surgical procedures in pets.
Who are the key players operating in the Maropitant market?
The primary manufacturer of Maropitant is Zoetis Inc., which markets it under the brand name Cerenia. Other players include generic manufacturers that are beginning to enter the market as patent protections expire, especially in Latin America, Asia-Pacific, and parts of Europe.
Which region will exhibit the fastest growth in the Maropitant market?
The Asia-Pacific region is expected to grow the fastest, fueled by rising disposable income, urbanization, and increased investment in veterinary care across countries like India, China, and Southeast Asia.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.